1,667
Views
7
CrossRef citations to date
0
Altmetric
Articles

Novel pyochelin-based PEGylated liposomes for enhanced delivery of antibiotics against resistant clinical isolates of Pseudomonas aeruginosa

, ORCID Icon, &
Pages 2043-2053 | Received 03 Aug 2017, Accepted 18 Nov 2017, Published online: 27 Nov 2017

References

  • DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004;53:37–50.
  • Boateng JS, Matthews KH, Stevens HN, et al. Wound healing dressings and drug delivery systems: a review. J Pharm Sci. 2008;97:2892–2923.
  • Chin-Hong PV, Guglielmo BJ. (2015). Common problems in infectious diseases & antimicrobial therapy. Current medical diagnosis and treatment. New York (NY): McGraw –Hill Medical; 2015
  • Breidenstein EB, de la Fuente-Nunez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19:419–426.
  • Xu ZQ, Flavin MT, Flavin J. Combating multidrug-resistant Gram-negative bacterial infections. Expert Opin Investig Drug. 2014;23:163–182.
  • Park K. Facing the truth about nanotechnology in drug delivery. ACS Nano. 2013;7:7442–7447.
  • Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev. 2015;115:10938–10966.
  • Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65:36–48.
  • Pinto-Alphandary H, Andremont A, Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents. 2000;13:155–168.
  • Al-Jamal WT, Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res. 2011;44:1094–1104.
  • Huang CM, Chen CH, Pornpattananangkul D, et al. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials. 2011;32:214–221.
  • Pushparaj SP, Jayshree N, Malathy Balaraman R, et al. Enhancement of antimicrobial activity by liposomal oleic acid-loaded antibiotics for the treatment of multidrug-resistant Pseudomonas aeruginosa. Artif Cells Nanomed Biotechnol. 2017. [Epub ahead of print]. doi: 10.1080/21691401.2017.1307209
  • Cassat JE, Skaar EP. Iron in infection and immunity. Cell Host Microbe. 2013;13:509–519.
  • Faraldo-Gómez JD, Sansom MS. Acquisition of siderophores in gram-negative bacteria. Nat Rev Mol Cell Biol. 2003;4:105–116.
  • Hider RC, Kong X. “Chemistry and biology of siderophores.”. Nat Prod Rep. 2010;27:637–657.
  • Braun V, Braun M. Active transport of iron and siderophore antibiotics. Curr Opin Microbiol. 2002;5:194–201.
  • Miller MJ, Malouin F. “Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates.”. Acc Chem Res. 1993;26:241–249.
  • Gorska A, Sloderbach A, Marszall MP. Siderophore–drug complexes: potential medicinal applications of the ‘Trojan horse’ strategy. Trends Pharmacol Sci. 2014;35:442–449.
  • O'neill AJ. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria. Expert Opin Investig Drug. 2008;17:297–302.
  • Cobessi D, Celia H, Pattus F. Crystal structure at high resolution of ferric-pyochelin and its membrane receptor FptA from Pseudomonas aeruginosa. J Mol Biol. 2005;352:893–904.
  • Brandel J, Humbert N, Elhabiri M, et al. Pyochelin, a siderophore of Pseudomonas aeruginosa: physicochemical characterization of the iron (III), copper (II) and zinc (II) complexes. Dalton Trans. 2012;41:2820–2834.
  • Ankenbauer RG, Quan HN. FptA, the Fe (III)-pyochelin receptor of Pseudomonas aeruginosa: a phenolate siderophore receptor homologous to hydroxamate siderophore receptors. J Bacteriol. 1994;176:307–319.
  • Pramanik A, Stroeher UW, Krejci J, et al. Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae. Int J Med Microbiol. 2007;297:459–469.
  • Daraee H, Etemadi A, Kouhi M, et al. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:381–391.
  • Alhariri M, Azghani A, Omri A. Liposomal antibiotics for the treatment of infectious diseases. Expert Opin Drug Deliv. 2013;10:1515–1532.
  • Lollo G, Rivera-Rodriguez GR, Bejaud J, et al. Polyglutamic acid–PEG nanocapsules as long circulating carriers for the delivery of docetaxel. Eur J Pharm Biopharm. 2014;87:47–54.
  • Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74:81–94.
  • Kulkarni HM, Jagannadham MV. Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria. Microbiology. 2014;160:2109–2121.
  • Noel S, Guillon L, Schalk IJ, et al. Synthesis of fluorescent probes based on the pyochelin siderophore scaffold. Org Lett. 2011;13:844–847.
  • Tian H, Tang Z, Zhuang X, et al. Biodegradable synthetic polymers: preparation, functionalization and biomedical application. Prog Polym Sci. 2012;37:237–280.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-Fifth Informational Supplement. Wayne (PA): CLSI; 2015. Document M100-S25.
  • Ferret C, Sterckeman T, Jean-Yves C, et al. Siderophore‐promoted dissolution of smectite by fluorescent Pseudomonas. Env Microbiol Rep. 2014;6:459–467.
  • Ji C, Miller PA, Miller MJ. Iron transport-mediated drug delivery: practical syntheses and in vitro antibacterial studies of tris-catecholate siderophore–aminopenicillin conjugates reveals selectively potent antipseudomonal activity. J Am Chem Soc. 2012;134:9898–9901.
  • Mislin GLA, Schalk IJ. Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa. Metallomics. 2014;6:408–420.
  • Heli H, Mirtorabi S, Karimian K. Advances in iron chelation: an update. Expert Opin Ther Pat. 2011;21:819–856.
  • Rivault F, Liebert C, Burger A, et al. Synthesis of pyochelin?norfloxacin conjugates. Bioorg Med Chem Lett. 2007;17:640–644.
  • Ankenbauer RG, Toyokuni T, Staley A, et al. Synthesis and biological activity of pyochelin, a siderophore of Pseudomonas aeruginosa. J Bacteriol. 1988;170:5344–5351.
  • Schlegel K, Taraz K, Budzikiewicz H. The stereoisomers of pyochelin, a siderophore of Pseudomonas aeruginosa. Biometals. 2004;17:409–414.
  • Carrion C, Domingo JC, De Madariaga MA. Preparation of long-circulating immunoliposomes using PEG–cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. Chem Phys Lipids. 2001;113:97–110.
  • Fatouros DG, Antimisiaris SG. Effect of amphiphilic drugs on the stability and zeta-potential of their liposome formulations: a study with prednisolone, diazepam, and griseofulvin. J Colloid Interf Sci. 2002;251:271–277.
  • Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Iron and infection: the heart of the matter. Fems Immunol Med Microbiol. 2005;43:325–330.
  • Oglesby-Sherrouse AG, Louise D, Nguyen AT, et al. The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa. Pathog Dis. 2014;70:307–320.
  • Rukholm G. Antibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time–kill study. Int J Antimicrob Agents. 2006;27:247–252.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.